U.S. flag

An official website of the United States government, Department of Justice.

BJA FY 20 Harold Rogers Prescription Drug Monitoring Program

Award Information

Award #
2020-PM-BX-0017
Funding Category
Competitive Discretionary
Location
Congressional District
Status
Past Project Period End Date
Funding First Awarded
2020
Total funding (to date)
$3,338,522

Description of original award (Fiscal Year 2020, $1,669,261)

The Harold Rogers Prescription Drug Monitoring Program (PDMP) enhances the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized agency.

PDMPs help state and local governments to detect and prevent the diversion and abuse of pharmaceutically controlled substances such as opioids and other prescription drugs. The Harold Rogers PDMP strengthens states’ and territories’ ability to plan, implement, or enhance PDMPs by accommodating local decision-making based on state laws and preferences, while encouraging the replication of promising practices. In addition to supporting the implementation and enhancement of PDMPs, the program can support the Administration’s priority of tracking prescribing across providers and states through the integration of PDMPs and Electronic Health Records (EHRs) and Health Information Exchanges (HIEs) which are essential to promoting safe and responsible prescribing, while also assuring appropriate pain care.

The applicant will focus on surveillance of stimulant prescribing patterns to inform interventions, ensuring timely and accurate data from dispensing pharmacies. It will also increase the use of the PDMP by prescribers and use PDMP data to inform prevention and intervention strategies, heightened by the need for investment in strengthening quality assurance processes and infrastructure. And the applicant will evaluate the impacts of recently implemented tools on PDMP utilization and clinical decisionmaking.

CA/NCF

Date Created: October 22, 2020